Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

Restricted access

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

✓ The authors report findings from a metaanalysis of all published randomized trials of prophylactic nimodipine used in patients who have experienced subarachnoid hemorrhage (SAH). Seven trials were included with a total of 1202 patients suitable for evaluation. Eight outcome measures were examined, including good versus other outcome, good or fair outcome versus other outcome, overall mortality, deficit and/or death attributed to vasospasm, infarction rate as judged by computerized tomography (CT), and deficit and/or death from rebleeding.

Nimodipine improved outcome according to all measures examined. The odds of good and of good plus fair outcomes were improved by ratios of 1.86:1 and 1.67:1, respectively, for nimodipine versus control (p < 0.005 for both measures). The odds of deficit and/or mortality attributed to vasospasm and CT-assessed infarction rate were reduced by ratios of 0.46:1 to 0.58:1 in the nimodipine group (p < 0.008 for all measures). Overall mortality was slightly reduced in the nimodipine group, but the trend was not statistically significant. The rebleeding rate was not increased by nimodipine. A metaregression yielded findings indicating that the treatment effect of nimodipine in individual trials was positively correlated with the severity of SAH in enrolled patients.

Although the majority of individual trials examined did not have statistically significant results at the p < 0.01 level according to most outcome measures, the metaanalyses confirmed the significant efficacy of prophylactic nimodipine in improving outcome after SAH under the conditions used in these trials.

Article Information

Contributor Notes

Address reprint requests to: Fred G. Barker, M.D., Neurosurgical Service, White 5, Massachusetts General Hospital, 32 Fruit Street, Boston, Massachusetts 02114.
Headings
References
  • 1.

    Adams HP Jr: Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review. Angiology 41:101010161990Adams HP Jr: Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: a review. Angiology 41:1010–1016 1990

    • Search Google Scholar
    • Export Citation
  • 2.

    Agresti A: Categorical Data Analysis. New York: John Wiley & Sons1990Agresti A: Categorical Data Analysis. New York: John Wiley & Sons 1990

    • Search Google Scholar
    • Export Citation
  • 3.

    Allen GSAhn HSPreziosi TJet al: Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:6196241983Allen GS Ahn HS Preziosi TJ et al: Cerebral arterial spasm—a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619–624 1983

    • Search Google Scholar
    • Export Citation
  • 4.

    Anderson JLPlatia EVHallstrom Aet al: Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Circulation 90:284328521994Anderson JL Platia EV Hallstrom A et al: Interaction of baseline characteristics with the hazard of encainide flecainide and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Circulation 90:2843–2852 1994

    • Search Google Scholar
    • Export Citation
  • 5.

    Barker FG II: Efficacy of prophylactic antibiotics for craniotomy: a metaanalysis. Neurosurgery 35:4844921994Barker FG II: Efficacy of prophylactic antibiotics for craniotomy: a metaanalysis. Neurosurgery 35:484–492 1994

    • Search Google Scholar
    • Export Citation
  • 6.

    Barker FG IIHeros RC: Clinical aspects of vasospasm. Neurosurg Clin North Am 1:2772881990Barker FG II Heros RC: Clinical aspects of vasospasm. Neurosurg Clin North Am 1:277–288 1990

    • Search Google Scholar
    • Export Citation
  • 7.

    Begg CBBerlin JA: Publication bias: a problem in interpreting medical data. J R Stat Soc (A) 151:4194631988Begg CB Berlin JA: Publication bias: a problem in interpreting medical data. J R Stat Soc (A) 151:419–463 1988

    • Search Google Scholar
    • Export Citation
  • 8.

    Berlin JAAntman EM: Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials 4:Doc No 1341994Berlin JA Antman EM: Advantages and limitations of metaanalytic regressions of clinical trials data. Online J Curr Clin Trials 4:Doc No 134 1994

    • Search Google Scholar
    • Export Citation
  • 9.

    Berlin JALaird NMSacks HSet al: A comparison of statistical methods for combining event rates from clinical trials. Stat Med 8:1411511989Berlin JA Laird NM Sacks HS et al: A comparison of statistical methods for combining event rates from clinical trials. Stat Med 8:141–151 1989

    • Search Google Scholar
    • Export Citation
  • 10.

    Brand RKragt H: Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med 11:207720821992Brand R Kragt H: Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med 11:2077–2082 1992

    • Search Google Scholar
    • Export Citation
  • 11.

    Brandt LSäveland HRomner Bet al: Does nimodipine eliminate arterial hypertension as a prognostic risk factor in subarachnoid haemorrhage? Br J Neurosurg 5:4854891991Brandt L Säveland H Romner B et al: Does nimodipine eliminate arterial hypertension as a prognostic risk factor in subarachnoid haemorrhage? Br J Neurosurg 5:485–489 1991

    • Search Google Scholar
    • Export Citation
  • 12.

    Cardiac Arrhythmia Pilot Study (CAPS) Investigators: Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Am J Cardiol 61:5015091988Cardiac Arrhythmia Pilot Study (CAPS) Investigators: Effects of encainide flecainide imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Am J Cardiol 61:501–509 1988

    • Search Google Scholar
    • Export Citation
  • 13.

    Cardiac Arrhythmia Suppression Trial Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:4064121989Cardiac Arrhythmia Suppression Trial Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412 1989

    • Search Google Scholar
    • Export Citation
  • 14.

    Chalmers TC: Problems induced by meta-analyses. Stat Med 10:9719801991Chalmers TC: Problems induced by meta-analyses. Stat Med 10:971–980 1991

    • Search Google Scholar
    • Export Citation
  • 15.

    Chyatte DFode NCSundt TM Jr: Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage. J Neurosurg 69:3263311988Chyatte D Fode NC Sundt TM Jr: Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage. J Neurosurg 69:326–331 1988

    • Search Google Scholar
    • Export Citation
  • 16.

    Cochran WG: The combination of estimates from different experiments. Biometrics 10:1011291954Cochran WG: The combination of estimates from different experiments. Biometrics 10:101–129 1954

    • Search Google Scholar
    • Export Citation
  • 17.

    Cook DJSackett DLSpitzer WO: Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 48:1671711995Cook DJ Sackett DL Spitzer WO: Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 48:167–171 1995

    • Search Google Scholar
    • Export Citation
  • 18.

    Cook RJSackett DL: The number needed to treat: a clinically useful measure of treatment effect. Br Med J 310:4524541995Cook RJ Sackett DL: The number needed to treat: a clinically useful measure of treatment effect. Br Med J 310:452–454 1995

    • Search Google Scholar
    • Export Citation
  • 19.

    DerSimonian RLaird N: Meta-analysis in clinical trials. Control Clin Trials 7:1771881986DerSimonian R Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177–188 1986

    • Search Google Scholar
    • Export Citation
  • 20.

    Desbordes JMAdes PEGuggiari M: Nimodipine intraveineuse dans le traitement curatif du vasospasme cérébral secondaire aux hémorragies méningées par rupture anévrysmale: étude comparative multicentrique. Agressologie 30:4384401989Desbordes JM Ades PE Guggiari M: Nimodipine intraveineuse dans le traitement curatif du vasospasme cérébral secondaire aux hémorragies méningées par rupture anévrysmale: étude comparative multicentrique. Agressologie 30:438–440 1989

    • Search Google Scholar
    • Export Citation
  • 21.

    Di Mascio RMarchioli RTognoni G: From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Clin Trials Meta-Analysis 29:57791994Di Mascio R Marchioli R Tognoni G: From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Clin Trials Meta-Analysis 29:57–79 1994

    • Search Google Scholar
    • Export Citation
  • 22.

    Dickersin KMin YI: Publication bias: the problem that won't go away. Ann N Y Acad Sci 703:1351481993Dickersin K Min YI: Publication bias: the problem that won't go away. Ann N Y Acad Sci 703:135–148 1993

    • Search Google Scholar
    • Export Citation
  • 23.

    Dickersin KMin YIMeinert CL: Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 267:3743781992Dickersin K Min YI Meinert CL: Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 267:374–378 1992

    • Search Google Scholar
    • Export Citation
  • 24.

    Dorsch NWC: A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part II: Management. J Clin Neurosci 1:78921994Dorsch NWC: A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part II: Management. J Clin Neurosci 1:78–92 1994

    • Search Google Scholar
    • Export Citation
  • 25.

    Dorsch NWCKing MT: A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part I: Incidence and effects. J Clin Neurosci 1:19261994Dorsch NWC King MT: A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage. Part I: Incidence and effects. J Clin Neurosci 1:19–26 1994

    • Search Google Scholar
    • Export Citation
  • 26.

    Easterbrook PJBerlin JAGopalan Ret al: Publication bias in clinical research. Lancet 337:8678721991Easterbrook PJ Berlin JA Gopalan R et al: Publication bias in clinical research. Lancet 337:867–872 1991

    • Search Google Scholar
    • Export Citation
  • 27.

    Echt DSLiebson PRMitchell LBet al: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:7817881991Echt DS Liebson PR Mitchell LB et al: Mortality and morbidity in patients receiving encainide flecainide or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781–788 1991

    • Search Google Scholar
    • Export Citation
  • 28.

    Eskridge JMNewell DWWinn HR: Endovascular treatment of vasospasm. Neurosurg Clin North Am 5:4374471994Eskridge JM Newell DW Winn HR: Endovascular treatment of vasospasm. Neurosurg Clin North Am 5:437–447 1994

    • Search Google Scholar
    • Export Citation
  • 29.

    Felson DT: Bias in meta-analytic research. J Clin Epidemiol 45:8858921992Felson DT: Bias in meta-analytic research. J Clin Epidemiol 45:885–892 1992

    • Search Google Scholar
    • Export Citation
  • 30.

    Flamm ESAdams HP JrBeck DWet al: Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 68:3934001988Flamm ES Adams HP Jr Beck DW et al: Dose-escalation study of intravenous nicardipine in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 68:393–400 1988

    • Search Google Scholar
    • Export Citation
  • 31.

    Fleiss JL: Statistical Methods for Rates and Proportionsed 2. New York: Wiley1981Fleiss JL: Statistical Methods for Rates and Proportions ed 2. New York: Wiley 1981

    • Search Google Scholar
    • Export Citation
  • 32.

    Frerebeau PJanny PTaquoi Get al: Traitement curatif du vasospasme des hémorragies méningées d'origine anévrysmale par la nimodipine intraveineuse. Etude coopérative multicentrique. Neurochirurgie 34:3833881988Frerebeau P Janny P Taquoi G et al: Traitement curatif du vasospasme des hémorragies méningées d'origine anévrysmale par la nimodipine intraveineuse. Etude coopérative multicentrique. Neurochirurgie 34:383–388 1988

    • Search Google Scholar
    • Export Citation
  • 33.

    Fujita SKawaguchi TShose Yet al: Flunarizine treatment in poor-grade aneurysm patients. Acta Neurochir 103:11171990Fujita S Kawaguchi T Shose Y et al: Flunarizine treatment in poor-grade aneurysm patients. Acta Neurochir 103:11–17 1990

    • Search Google Scholar
    • Export Citation
  • 34.

    Gilsbach JM: Nimodipine in the prevention of ischaemic deficits after aneurysmal subarachnoid haemorrhage. An analysis of recent clinical studies. Acta Neurochir Suppl 45:41501988Gilsbach JM: Nimodipine in the prevention of ischaemic deficits after aneurysmal subarachnoid haemorrhage. An analysis of recent clinical studies. Acta Neurochir Suppl 45:41–50 1988

    • Search Google Scholar
    • Export Citation
  • 35.

    Gilsbach JMReulen HJLjunggren Bet al: Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter, double-blind, dose-comparison study. Neurosurgery 26:4584641990Gilsbach JM Reulen HJ Ljunggren B et al: Early aneurysm surgery and preventive therapy with intravenously administered nimodipine: a multicenter double-blind dose-comparison study. Neurosurgery 26:458–464 1990

    • Search Google Scholar
    • Export Citation
  • 36.

    Haley EC JrKassell NFAlves WMet al: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:7867901995Haley EC Jr Kassell NF Alves WM et al: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786–790 1995

    • Search Google Scholar
    • Export Citation
  • 37.

    Haley EC JrKassell NFTorner JCet al: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78:5375471993Haley EC Jr Kassell NF Torner JC et al: A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78:537–547 1993

    • Search Google Scholar
    • Export Citation
  • 38.

    Haley EC JrKassell NFTorner JCet al: A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 78:5485531993Haley EC Jr Kassell NF Torner JC et al: A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 78:548–553 1993

    • Search Google Scholar
    • Export Citation
  • 39.

    Han DHLee SHLee SH: Effect of nimodipine treatment on outcome in surgical cases of aneurysmal SAH. J Neurosurg 78:346A1993Han DH Lee SH Lee SH: Effect of nimodipine treatment on outcome in surgical cases of aneurysmal SAH. J Neurosurg 78:346A 1993

    • Search Google Scholar
    • Export Citation
  • 40.

    Higashida RTHalbach VVCahan LDet al: Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 71:6486531989Higashida RT Halbach VV Cahan LD et al: Transluminal angioplasty for treatment of intracranial arterial vasospasm. J Neurosurg 71:648–653 1989

    • Search Google Scholar
    • Export Citation
  • 41.

    Hongo KKobayashi S: Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage. Neurol Res 15:2182241993Hongo K Kobayashi S: Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage. Neurol Res 15:218–224 1993

    • Search Google Scholar
    • Export Citation
  • 42.

    Horner SM: Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Metaanalysis of magnesium in acute myocardial infarction. Circulation 86:7747791992Horner SM: Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Metaanalysis of magnesium in acute myocardial infarction. Circulation 86:774–779 1992

    • Search Google Scholar
    • Export Citation
  • 43.

    Hunt WEHess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14201968Hunt WE Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14–20 1968

    • Search Google Scholar
    • Export Citation
  • 44.

    ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group: ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:6696851995ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group: ISIS-4: a randomised factorial trial assessing early oral captopril oral mononitrate and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 345:669–685 1995

    • Search Google Scholar
    • Export Citation
  • 45.

    Jan MBuchheit FTremoulet M: Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 23:1541571988Jan M Buchheit F Tremoulet M: Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasm after rupture of intracranial aneurysms. Neurosurgery 23:154–157 1988

    • Search Google Scholar
    • Export Citation
  • 46.

    Jennett BBond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:4804841975Jennett B Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480–484 1975

    • Search Google Scholar
    • Export Citation
  • 47.

    Jones DR: Meta-analysis: weighing the evidence. Stat Med 14:1371491995Jones DR: Meta-analysis: weighing the evidence. Stat Med 14:137–149 1995

    • Search Google Scholar
    • Export Citation
  • 48.

    Kassell NFTorner JCHaley EC Jret al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18361990Kassell NF Torner JC Haley EC Jr et al: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18–36 1990

    • Search Google Scholar
    • Export Citation
  • 49.

    Langley MSSorkin EM: Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37:6696991989Langley MS Sorkin EM: Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascular disease. Drugs 37:669–699 1989

    • Search Google Scholar
    • Export Citation
  • 50.

    Mayberg MRBatjer HHDacey Ret al: Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25:231523281994Mayberg MR Batjer HH Dacey R et al: Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council American Heart Association. Stroke 25:2315–2328 1994

    • Search Google Scholar
    • Export Citation
  • 51.

    Mee EDorrance DLowe Det al: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22:4844911988Mee E Dorrance D Lowe D et al: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 22:484–491 1988

    • Search Google Scholar
    • Export Citation
  • 52.

    Mehta CRPatel NRGray R: On computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables. J Am Stat Assoc 80:9699731985Mehta CR Patel NR Gray R: On computing an exact confidence interval for the common odds ratio in several 2 × 2 contingency tables. J Am Stat Assoc 80:969–973 1985

    • Search Google Scholar
    • Export Citation
  • 53.

    Mercier PAlhayek GRizk Tet al: Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study. Neurosurgery 34:30371994Mercier P Alhayek G Rizk T et al: Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study. Neurosurgery 34:30–37 1994

    • Search Google Scholar
    • Export Citation
  • 54.

    Mercier PAlhayek GRizk Tet al: Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study. Neurosurgery 35:5421994 (Letter)Mercier P Alhayek G Rizk T et al: Are the calcium antagonists really useful in cerebral aneurysmal surgery? A retrospective study. Neurosurgery 35:542 1994 (Letter)

    • Search Google Scholar
    • Export Citation
  • 55.

    Mercier PAlhayek GRizk Tet al: Les anticalciques sont-ils réellement utiles en chirurgie anévrysmale cérébrale? Neurochirurgie 39:1491561993Mercier P Alhayek G Rizk T et al: Les anticalciques sont-ils réellement utiles en chirurgie anévrysmale cérébrale? Neurochirurgie 39:149–156 1993

    • Search Google Scholar
    • Export Citation
  • 56.

    Messeter KBrandt LLjunggren Bet al: Prediction and prevention of delayed ischemic dysfunction after aneurysmal subarachnoid hemorrhage and early operation. Neurosurgery 20:5485531987Messeter K Brandt L Ljunggren B et al: Prediction and prevention of delayed ischemic dysfunction after aneurysmal subarachnoid hemorrhage and early operation. Neurosurgery 20:548–553 1987

    • Search Google Scholar
    • Export Citation
  • 57.

    Miyaoka MSato KIshii S: A clinical study of the relationship of timing to outcome of surgery for ruptured cerebral aneurysms. A retrospective analysis of 1622 cases. J Neurosurg 79:3733781993Miyaoka M Sato K Ishii S: A clinical study of the relationship of timing to outcome of surgery for ruptured cerebral aneurysms. A retrospective analysis of 1622 cases. J Neurosurg 79:373–378 1993

    • Search Google Scholar
    • Export Citation
  • 58.

    Neil-Dwyer GMee EDorrance Det al: Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 8 (Suppl K):41471987Neil-Dwyer G Mee E Dorrance D et al: Early intervention with nimodipine in subarachnoid haemorrhage. Eur Heart J 8 (Suppl K):41–47 1987

    • Search Google Scholar
    • Export Citation
  • 59.

    Newell DWEskridge JMMayberg MRet al: Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 71:6546601989Newell DW Eskridge JM Mayberg MR et al: Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg 71:654–660 1989

    • Search Google Scholar
    • Export Citation
  • 60.

    Öhman JHeiskanen O: Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:6836861988Öhman J Heiskanen O: Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 69:683–686 1988

    • Search Google Scholar
    • Export Citation
  • 61.

    Öhman JServo AHeiskanen O: Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 74:8131991Öhman J Servo A Heiskanen O: Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 74:8–13 1991

    • Search Google Scholar
    • Export Citation
  • 62.

    Öhman JServo AHeiskanen O: Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 74:14201991Öhman J Servo A Heiskanen O: Risks factors for cerebral infarction in good-grade patients after aneurysmal subarachnoid hemorrhage and surgery: a prospective study. J Neurosurg 74:14–20 1991

    • Search Google Scholar
    • Export Citation
  • 63.

    Olkin I: Meta-analysis: reconciling the results of independent studies. Stat Med 14:4574721995Olkin I: Meta-analysis: reconciling the results of independent studies. Stat Med 14:457–472 1995

    • Search Google Scholar
    • Export Citation
  • 64.

    Origitano TCWascher TMReichman OHet al: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“Triple-H”) therapy after subarachnoid hemorrhage. Neurosurgery 27:7297401990Origitano TC Wascher TM Reichman OH et al: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“Triple-H”) therapy after subarachnoid hemorrhage. Neurosurgery 27:729–740 1990

    • Search Google Scholar
    • Export Citation
  • 65.

    Pellettieri LBolander HCarlsson Het al: Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: no significant difference between present and historical results. Surg Neurol 30:1801861988Pellettieri L Bolander H Carlsson H et al: Nimodipine treatment of selected good-risk patients with subarachnoid hemorrhage: no significant difference between present and historical results. Surg Neurol 30:180–186 1988

    • Search Google Scholar
    • Export Citation
  • 66.

    Peroutka SJBanghart SBAllen GS: Relative potency and selectivity of calcium antagonists used in the treatment of migraine. Headache 24:55581984Peroutka SJ Banghart SB Allen GS: Relative potency and selectivity of calcium antagonists used in the treatment of migraine. Headache 24:55–58 1984

    • Search Google Scholar
    • Export Citation
  • 67.

    Petruk KCWest MMohr Get al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:5055171988Petruk KC West M Mohr G et al: Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 68:505–517 1988

    • Search Google Scholar
    • Export Citation
  • 68.

    Philippon JGrob RDagreou Fet al: Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 82:1101141986Philippon J Grob R Dagreou F et al: Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochir 82:110–114 1986

    • Search Google Scholar
    • Export Citation
  • 69.

    Pickard JDMurray GDIllingworth Ret al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 298:6366421989Pickard JD Murray GD Illingworth R et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 298:636–642 1989

    • Search Google Scholar
    • Export Citation
  • 70.

    Popovic EADanks RASiu KH: Experience with nimodipine in aneurysmal subarachnoid haemorrhage. Med J Aust 158:91941993Popovic EA Danks RA Siu KH: Experience with nimodipine in aneurysmal subarachnoid haemorrhage. Med J Aust 158:91–94 1993

    • Search Google Scholar
    • Export Citation
  • 71.

    Rosenthal R: The “file drawer problem” and tolerance for null results. Psychol Bull 86:6386411979Rosenthal R: The “file drawer problem” and tolerance for null results. Psychol Bull 86:638–641 1979

    • Search Google Scholar
    • Export Citation
  • 72.

    Rousseaux PGomis PBazin Aet al: Comparaison de deux séries consécutives d'hemorragies méningées anévrysmales avec et sans nimodipine et étude de la courbe thermique. Neurochirurgie 39:1571651993Rousseaux P Gomis P Bazin A et al: Comparaison de deux séries consécutives d'hemorragies méningées anévrysmales avec et sans nimodipine et étude de la courbe thermique. Neurochirurgie 39:157–165 1993

    • Search Google Scholar
    • Export Citation
  • 73.

    Sekhar LNWechsler LRYonas Het al: Value of transcranial Doppler examination in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 22:8138211988Sekhar LN Wechsler LR Yonas H et al: Value of transcranial Doppler examination in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 22:813–821 1988

    • Search Google Scholar
    • Export Citation
  • 74.

    Senn S: Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med 13:2932961994 (Letter)Senn S: Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat Med 13:293–296 1994 (Letter)

    • Search Google Scholar
    • Export Citation
  • 75.

    Shibuya MSuzuki YSugita Ket al: Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir 107:11151990Shibuya M Suzuki Y Sugita K et al: Dose escalation trial of a novel calcium antagonist AT877 in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir 107:11–15 1990

    • Search Google Scholar
    • Export Citation
  • 76.

    Shibuya MSuzuki YSugita Ket al: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:5715771992Shibuya M Suzuki Y Sugita K et al: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571–577 1992

    • Search Google Scholar
    • Export Citation
  • 77.

    Sprent P: Applied Nonparametric Statistical Methodsed 2. London: Chapman & Hall1993Sprent P: Applied Nonparametric Statistical Methods ed 2. London: Chapman & Hall 1993

    • Search Google Scholar
    • Export Citation
  • 78.

    Sundt TM JrKobayashi SFode NCet al: Results and complications of surgical management of 809 intracranial aneurysms in 722 cases. Related and unrelated to grade of patient, type of aneurysm, and timing of surgery. J Neurosurg 56:7537651982Sundt TM Jr Kobayashi S Fode NC et al: Results and complications of surgical management of 809 intracranial aneurysms in 722 cases. Related and unrelated to grade of patient type of aneurysm and timing of surgery. J Neurosurg 56:753–765 1982

    • Search Google Scholar
    • Export Citation
  • 79.

    Takagi TKuwahara MNagai Het al: [Effect of calcium antagonist (diltiazem) on symptomatic cerebral vasospasm.] Neurol Med Chir 26:8638691986 (Jpn)Takagi T Kuwahara M Nagai H et al: [Effect of calcium antagonist (diltiazem) on symptomatic cerebral vasospasm.] Neurol Med Chir 26:863–869 1986 (Jpn)

    • Search Google Scholar
    • Export Citation
  • 80.

    Teo KKYusuf S: Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence. Drugs 46:3473591993Teo KK Yusuf S: Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence. Drugs 46:347–359 1993

    • Search Google Scholar
    • Export Citation
  • 81.

    Teo KKYusuf SCollins Ret al: Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. Br Med J 303:149915031991Teo KK Yusuf S Collins R et al: Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. Br Med J 303:1499–1503 1991

    • Search Google Scholar
    • Export Citation
  • 82.

    Tettenborn DDycka J: Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 21 (Suppl IV):85891990Tettenborn D Dycka J: Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 21 (Suppl IV):85–89 1990

    • Search Google Scholar
    • Export Citation
  • 83.

    Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. Br Med J 309:135113551994Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. Br Med J 309:1351–1355 1994

    • Search Google Scholar
    • Export Citation
  • 84.

    Welty TE: Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage. Clin Pharmacol 6:9409461987Welty TE: Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage. Clin Pharmacol 6:940–946 1987

    • Search Google Scholar
    • Export Citation
  • 85.

    Zelen M: The analysis of several 2×2 contingency tables. Biometrika 58:1291371971Zelen M: The analysis of several 2×2 contingency tables. Biometrika 58:129–137 1971

    • Search Google Scholar
    • Export Citation
Cited By
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 847 618 38
Full Text Views 433 154 8
PDF Downloads 220 78 3
EPUB Downloads 0 0 0
PubMed
Google Scholar